Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Waldeyer's Ring Marginal Zone B-Cell Lymphoma: Which Is Their Clinical and Prognostic Feature, Nodal or Extranodal?

Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Suee Lee, Cheolwon Suh, MD, Dae Ho Lee, Soon il Lee, Hye Jin Kang, Chul Won Choi, Seong Hyun Jeong, Jinny Park, Moo-Kon Song, MD, Hyo Jung Kim, MD, PhD, Jung Hye Kwon, Jae-Yong Kwak, Sung Hwa Bae, Byeong-Bae Park

Blood (2010) 116 (21): 5084.

https://doi.org/10.1182/blood.V116.21.5084.5084

Published: 2010

Journal Articles

Comparison Between CD20-Negative and CD20-Positive Diffuse Large B Cell Lymphoma; Characteristics and Clinical Outcome

Jungmin Jo, M.D, Changhoon Yoo, M.D, Yongchel Ahn, MD, Seong Joon Park, M.D, Shin Kim, RN, Dae Ho Lee, MD, Sang We Kim, MD, Jungsin Lee, MD, Cheolwon Suh, MD

Blood (2010) 116 (21): 4891.

https://doi.org/10.1182/blood.V116.21.4891.4891

Published: 2010

Journal Articles

Short Course Adjuvant Chemotherapy for Localized Diffuse Large B-Cell Lymphoma After Complete Resection.

Jungmin Jo, M.D, Changhoon Yoo, M.D, Yongchel Ahn, M.D, Seong Joon Park, M.D, Dae Ho Lee, M.D, Sang-We Kim, M.D, Jungsin Lee, MD, Cheolwon Suh, MD

Blood (2010) 116 (21): 2824.

https://doi.org/10.1182/blood.V116.21.2824.2824

Published: 2010

Journal Articles

PROGNOSTIC SIGNIFICANCE of CD68 EXPRESSION for Korean PATIENTS with HODGKIN'S LYMPHOMA

Dok Hyun Yoon, MD, Young Wha Koh, MD, Shin Kim, RN, Chan-Sik Park, Dae Ho Lee, Sang-We Kim, Sang-wook Lee, Cheolwon Suh, MD, Jooryung Huh, MD

Blood (2010) 116 (21): 3888.

https://doi.org/10.1182/blood.V116.21.3888.3888

Published: 2010

Journal Articles

Matched Pair Analysis Comparing the Outcomes of Primary Breast and Nodal Diffuse Large B Cell Lymphoma In Patients Treated with R-Chop; Consortium for Improving Survival of Lymphoma (CISL) Study.

Ho-Young Yhim, Jae-Yong Kwak, Hye Jin Kang, Seok Jin Kim, MD, PhD, Won Seog Kim, Jin Seok Kim, Chul Won Choi, Hyeon Seok Eom, Jeong-A Kim, Jae Hoon Lee, MD, PhD, Jong Ho Won, Hyeok Shim, MD, Dae Ho Lee, Cheolwon Suh, MD

Blood (2010) 116 (21): 1790.

https://doi.org/10.1182/blood.V116.21.1790.1790

Published: 2010

Journal Articles

AUTOLOGOUS STEM CELL TRANSPLANTATION with INTRAVENOUS BUSULFAN, CYCLOPHOSPHAMIDE, and ETOPOSIDE as First-LINE TREATMENT of PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA in a SINGLE CENTER.

Dok Hyun Yoon, MD, Dae Ro Choi, Byeong Seok Sohn, MD, Shin Kim, Dae Ho Lee, M.D., Sang-We Kim, Jung Shin Lee, M.D., Sang-Wook Lee, Jooryung Huh, MD, Cheolwon Suh, MD

Blood (2009) 114 (22): 1219.

https://doi.org/10.1182/blood.V114.22.1219.1219

Published: 2009

Journal Articles

Prognostic Significance of Circulating Epstein-Barr Virus (EBV) DNA in Non-Hodgkin's Lymphoma.

Myoung Joo Kang, M.D., Yoo Jin Cho, M.D., Heui June Ahn, M.D., Shin Kim, Dae Ho Lee, M.D., Sang We Kim, M.D., Hyun-Sook Chi, M.D., Cheolwon Suh, M.D.

Blood (2009) 114 (22): 1936.

https://doi.org/10.1182/blood.V114.22.1936.1936

Published: 2009

Journal Articles

SIGNIFICANCE of ABSOLUTE LYMPHOCYTE COUNT at RELAPSE as a PROGNOSTIC FACTOR in PATIENTS with T-CELL NON-HODGKIN'S LYMPHOMA.

Dae Ro Choi, M.D., Dok Hyun Yoon, M.D., Heui June Ahn, M.D., Yoojin Cho, M.D., Eun Kyoung Kim, M.D., Shin Kim, Jooryung Huh, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Jung Shin Lee, M.D., Cheolwon Suh, M.D.

Blood (2009) 114 (22): 2939.

https://doi.org/10.1182/blood.V114.22.2939.2939

Published: 2009

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma: A Single Center Experience in Korea.

Heui June Ahn, M.D., Yoo Jin Cho, M.D., Myoung Joo Kang, M.D., Dae Ro Choi, M.D., Shin Kim, Dae Ho Lee, M.D., Sang We Kim, M.D., Jung Shin Lee, M.D., Jooryung Huh, MD, Cheolwon Suh, M.D.

Blood (2009) 114 (22): 5013.

https://doi.org/10.1182/blood.V114.22.5013.5013

Published: 2009

Journal Articles

Relapsed Marginal Zone B-Cell Lymphoma: Clinical Features and Treatment Outcome.

Blood (2009) 114 (22): 5017.

https://doi.org/10.1182/blood.V114.22.5017.5017

Published: 2009

Journal Articles

Prognostic Impact of Mid-Treatment PET in Patients with Diffuse Large B-Cell Lymphoma Who Achieved Metabolic CR at Post-Treatment PET

Changhoon Yoo, Jeong-Eun Kim, MD, Byeong Seok Sohn, MD, Dok Hyun Yoon, MD, Shin Kim, Dae Ho Lee, M.D., Sang We Kim, Jung Shin Lee, M.D., Cheolwon Suh

Blood (2009) 114 (22): 3949.

https://doi.org/10.1182/blood.V114.22.3949.3949

Published: 2009

Journal Articles

Excessive Toxicity of Once Daily Intravenous Busulfan, Melphalan, and Thiotepa Followed by Autologous Stem Cell Transplantation On Patients with Non-Hodgkin's Lymphoma.

Jong-Ho Won, M.D., Ph.D., Sang-Cheol Lee, M.D., Seok Jin Kim, M.D., Ph.D., Dae Ho Lee, M.D., Ph.D., Won Seog Kim, M.D., Ph.D., Cheolwon Suh, M.D., Ph.D., Hee-Sook Park, M.D., Ph.D.

Blood (2009) 114 (22): 4361.

https://doi.org/10.1182/blood.V114.22.4361.4361

Published: 2009

Journal Articles

The Role of High Dose Chemotherapy/Autologous Stem Cell Transplantation for Salvage Treatment for Relapsed Peripheral T Cell Lymphoma.

Yoojin Cho, MD, Myoung Joo Kang, MD, Dae Ro Choi, MD, Eun Kyoung Kim, MD, Shin Kim, Dae Ho Lee, MD, Sang We Kim, MD, Jooryung Huh, MD, Jeong Shin Lee, MD, Cheolwon Suh, M.D.

Blood (2009) 114 (22): 4363.

https://doi.org/10.1182/blood.V114.22.4363.4363

Published: 2009

Journal Articles

The Utility of the Follow-up with Serum Free Light Chain After Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Measurable M-Protein.

Byeong Seok Sohn, M.D., Eun Kyoung Kim, M.D., Dok Hyun Yoon, M.D., Myoung Joo Kang, M.D., Dae Ro Choi, M.D., Heui June Ahn, M.D., Yoo Jin Cho, M.D., Kyu-pyo Kim, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Cheolwon Suh, M.D., Jung Shin Lee, M.D.

Blood (2009) 114 (22): 4878.

https://doi.org/10.1182/blood.V114.22.4878.4878

Published: 2009

Journal Articles

Interim Report of Phase II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients with Disseminated Stage Diffuse Large B-Cell Lymphoma.

Jeong Eun Kim, MD, Dae Ho Lee, M.D., Soon Il Lee, Jae Hoon Lee, Won Seog Kim, Bora Yoon, Cheolwon Suh, MD

Blood (2009) 114 (22): 2688.

https://doi.org/10.1182/blood.V114.22.2688.2688

Published: 2009

Journal Articles

The Role of An Early Interim 18 F-FDG PET/CT for Prediction of Outcomes of Patients with Peripheral T Cell Lymphoma

Yoon Hee Choi, MD, Byung Woog Kang, MD, Hyun Soo Hong, MD, Chul Kim, MD, Geundoo Jang, MD, Sung Sook Lee, MD, Jin Sook Ryu, MD, Jooryung Huh, MD, Dae Ho Lee, MD, Sang We Kim, MD, Jung Shin Lee, MD, Cheolwon Suh, MD

Blood (2008) 112 (11): 5272.

https://doi.org/10.1182/blood.V112.11.5272.5272

Published: 2008

Journal Articles

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

Jeong-Eun Kim, Cheolwon Suh, MD, Yunsuk Choi, Eun Kyoung Kim, Byeong Seok Sohn, Inkeun Park, Dok Hyun Yoon, Changhoon Yoo, Geundoo Jang, Shin Kim, Dae Ho Lee, Sang -We Kim, Jung Shin Lee

Blood (2008) 112 (11): 4439.

https://doi.org/10.1182/blood.V112.11.4439.4439

Published: 2008

Journal Articles

The Role of Prophylactic Antimicrobials during Autologous Stem Cell Transplantation: A Single Center Experience

Byeong Seok Sohn, M.D., Dok Hyun Yoon, M.D., Shin Kim, R.N., Dae Ho Lee, M.D., Sang-We Kim, M.D., Jooryung Huh, M.D., Jung Shin Lee, M.D., Cheolwon Suh, M.D.

Blood (2008) 112 (11): 4375.

https://doi.org/10.1182/blood.V112.11.4375.4375

Published: 2008

Journal Articles

A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.

Geundoo Jang, MD, Sun-Jin Sym, MD, Shin Kim, Dae Ho Lee, MD, Sang We Kim, MD, Jooryung Huh, MD, Won Seog Kim, MD, Cheolwon Suh, MD

Blood (2007) 110 (11): 4446.

https://doi.org/10.1182/blood.V110.11.4446.4446

Published: 2007

Journal Articles

Initial Cytoreductive Treatment with Thalidomide Plus Bolus Vincristine/Doxorubicin and Reduced Dexamethasone (T-bVAd) Followed by Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma.

Jae-Cheol Jo, Byung Wook Kang, Sun Jin Sym, Sung Sook Lee, Geundoo Jang, Dae Ho Lee, Sang-We Kim, Cheolwon Suh

Blood (2007) 110 (11): 5094.

https://doi.org/10.1182/blood.V110.11.5094.5094

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Waldeyer's Ring Marginal Zone B-Cell Lymphoma: Which Is Their Clinical and Prognostic Feature, Nodal or Extranodal?

Comparison Between CD20-Negative and CD20-Positive Diffuse Large B Cell Lymphoma; Characteristics and Clinical Outcome

Short Course Adjuvant Chemotherapy for Localized Diffuse Large B-Cell Lymphoma After Complete Resection.

PROGNOSTIC SIGNIFICANCE of CD68 EXPRESSION for Korean PATIENTS with HODGKIN'S LYMPHOMA

Matched Pair Analysis Comparing the Outcomes of Primary Breast and Nodal Diffuse Large B Cell Lymphoma In Patients Treated with R-Chop; Consortium for Improving Survival of Lymphoma (CISL) Study.

AUTOLOGOUS STEM CELL TRANSPLANTATION with INTRAVENOUS BUSULFAN, CYCLOPHOSPHAMIDE, and ETOPOSIDE as First-LINE TREATMENT of PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA in a SINGLE CENTER.

Prognostic Significance of Circulating Epstein-Barr Virus (EBV) DNA in Non-Hodgkin's Lymphoma.

SIGNIFICANCE of ABSOLUTE LYMPHOCYTE COUNT at RELAPSE as a PROGNOSTIC FACTOR in PATIENTS with T-CELL NON-HODGKIN'S LYMPHOMA.

Primary Mediastinal Large B-Cell Lymphoma: A Single Center Experience in Korea.

Relapsed Marginal Zone B-Cell Lymphoma: Clinical Features and Treatment Outcome.

Prognostic Impact of Mid-Treatment PET in Patients with Diffuse Large B-Cell Lymphoma Who Achieved Metabolic CR at Post-Treatment PET

Excessive Toxicity of Once Daily Intravenous Busulfan, Melphalan, and Thiotepa Followed by Autologous Stem Cell Transplantation On Patients with Non-Hodgkin's Lymphoma.

The Role of High Dose Chemotherapy/Autologous Stem Cell Transplantation for Salvage Treatment for Relapsed Peripheral T Cell Lymphoma.

The Utility of the Follow-up with Serum Free Light Chain After Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Measurable M-Protein.

Interim Report of Phase II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients with Disseminated Stage Diffuse Large B-Cell Lymphoma.

The Role of An Early Interim 18 F-FDG PET/CT for Prediction of Outcomes of Patients with Peripheral T Cell Lymphoma

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

The Role of Prophylactic Antimicrobials during Autologous Stem Cell Transplantation: A Single Center Experience

A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.

Initial Cytoreductive Treatment with Thalidomide Plus Bolus Vincristine/Doxorubicin and Reduced Dexamethasone (T-bVAd) Followed by Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only